Literature DB >> 22891311

Hippocampal nitric oxide contributes to sex difference in affective behaviors.

Yao Hu1, Dan-Lian Wu, Chun-Xia Luo, Li-Juan Zhu, Jing Zhang, Hai-Yin Wu, Dong-Ya Zhu.   

Abstract

Mechanisms underlying the female preponderance in affective disorders are poorly understood. Here we show that hippocampal nitric oxide (NO) plays a role in the sex difference of depression-like behaviors in rodents. Female mice had substantially lower NO production in the hippocampus and were significantly more likely to display negative affective behaviors than their male littermates. Eliminating the difference in the basal hippocampal NO level between male and female mice mended the sex gap of affective behaviors. Estradiol exerted a positive control on hippocampal NO production via estrogen receptor-β-mediated neuronal NO synthase expression. Thus, low estrogen in the female hippocampus accounts for lower local NO than in the male hippocampus. Although estrogen has important significance in modulating affective behaviors, it is not estrogen but NO in the hippocampus that mediates the sex difference of affective behaviors directly, because hippocampal NO was necessary for the behavioral effects of estradiol, and NO was an independent factor in modulating behaviors. Stress promoted hippocampal NO production in males because of glucocorticoid release, thus leading to local NO excess. In contrast, stress suppressed NO production in females because of decreased estrogen, thereby resulting in hippocampal NO shortage. Whereas activating cAMP response element binding protein (CREB) rescued the depression-like effects of the intrahippocampal NO donor diethylenetriamine/nitric oxide adduct (DETA/NONOate), inactivating CREB abolished the antidepressant-like effects of the intrahippocampal NO donor DETA/NONOate. Our findings suggest a molecular mechanism underlying the sex difference of affective behaviors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891311      PMCID: PMC3435162          DOI: 10.1073/pnas.1207461109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression.

Authors:  Bhavya Voleti; Keith Q Tanis; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2011-09-19       Impact factor: 13.382

2.  Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21 days of restraint stress.

Authors:  E Kitraki; O Kremmyda; D Youlatos; M N Alexis; C Kittas
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

3.  Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein.

Authors:  D D Murphy; M Segal
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Sex difference in the phosphorylation of cAMP response element binding protein (CREB) in neonatal rat brain.

Authors:  A P Auger; D P Hexter; M M McCarthy
Journal:  Brain Res       Date:  2001-01-26       Impact factor: 3.252

Review 5.  The G-protein-coupled estrogen receptor GPER in health and disease.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Nat Rev Endocrinol       Date:  2011-08-16       Impact factor: 43.330

6.  Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase.

Authors:  R J Nelson; G E Demas; P L Huang; M C Fishman; V L Dawson; T M Dawson; S H Snyder
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

7.  Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction.

Authors:  R M Shansky; C Glavis-Bloom; D Lerman; P McRae; C Benson; K Miller; L Cosand; T L Horvath; A F T Arnsten
Journal:  Mol Psychiatry       Date:  2004-05       Impact factor: 15.992

8.  Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats.

Authors:  Ji Qiang Zhang; Wen Qin Cai; De Shan Zhou; Bing Yin Su
Journal:  Brain Res       Date:  2002-05-10       Impact factor: 3.252

9.  Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.

Authors:  Luca Santarelli; Michael Saxe; Cornelius Gross; Alexandre Surget; Fortunato Battaglia; Stephanie Dulawa; Noelia Weisstaub; James Lee; Ronald Duman; Ottavio Arancio; Catherine Belzung; René Hen
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728

10.  Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.

Authors:  Lee S Cohen; Claudio N Soares; Jennifer R Poitras; Jennifer Prouty; Allison B Alexander; Jan L Shifren
Journal:  Am J Psychiatry       Date:  2003-08       Impact factor: 18.112

View more
  27 in total

1.  P-selectin-mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors.

Authors:  Charlotte D'Mello; Kiarash Riazi; Tai Le; Katarzyna M Stevens; Arthur Wang; Derek M McKay; Quentin J Pittman; Mark G Swain
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  CAPON-nNOS coupling can serve as a target for developing new anxiolytics.

Authors:  Li-Juan Zhu; Ting-You Li; Chun-Xia Luo; Nan Jiang; Lei Chang; Yu-Hui Lin; Hai-Hui Zhou; Chen Chen; Yu Zhang; Wei Lu; Li-Yan Gao; Yu Ma; Qi-Gang Zhou; Qin Hu; Xiao-Ling Hu; Jing Zhang; Hai-Yin Wu; Dong-Ya Zhu
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

3.  Activation of Sigma-1 Receptor Alleviates Postpartum Estrogen Withdrawal-Induced "Depression" Through Restoring Hippocampal nNOS-NO-CREB Activities in Mice.

Authors:  Suyun Zhang; Juan Hong; Tingting Zhang; Jie Wu; Ling Chen
Journal:  Mol Neurobiol       Date:  2016-03-31       Impact factor: 5.590

4.  Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.

Authors:  Yudong Gao; Scott A Heldt
Journal:  Behav Neurosci       Date:  2015-02       Impact factor: 1.912

5.  nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety.

Authors:  Li-Juan Zhu; Hu-Jiang Shi; Lei Chang; Cheng Cheng Zhang; Meng Si; Na Li; Dong-Ya Zhu
Journal:  Br J Pharmacol       Date:  2020-05-28       Impact factor: 8.739

6.  Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5.

Authors:  Chun-Yu Yin; Shu-Ying Huang; Ling Gao; Yu-Hui Lin; Lei Chang; Hai-Yin Wu; Dong-Ya Zhu; Chun-Xia Luo
Journal:  J Neurosci       Date:  2021-01-26       Impact factor: 6.167

7.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

8.  17α-ethinyl estradiol attenuates depressive-like behavior through GABAA receptor activation/nitrergic pathway blockade in ovariectomized mice.

Authors:  Seyed Soheil Saeedi Saravi; Alireza Arefidoust; Rahele Yaftian; Seyed Sobhan Saeedi Saravi; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2016-02-16       Impact factor: 4.530

Review 9.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

10.  On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.

Authors:  Seyed Soheil Saeedi Saravi; Roya Amirkhanloo; Alireza Arefidoust; Rahele Yaftian; Seyed Sobhan Saeedi Saravi; Mohammad Shokrzadeh; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2015-11-19       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.